Cybersecurity leader earns highest unclassified level of authorization to protect extensive range of mission critical DoD systems CrowdStrike (NASDAQ:CRWD) today announced that it has been granted an Impact

CRWD

374Water Inc Files For Mixed Shelf Of Up To $200M

By Benzinga Newsdesk

December 22, 7:07 AM

https://www.sec.gov/Archives/edgar/data/933972/000165495422016825/scwo_s3.htm

SCWO

Can-Fite To Submit FDA & EMA Registration Plans For Piclidenoson In The Oral Treatment Of Moderate To Severe Psoriasis

By Bill Haddad

July 11, 7:02 AM

Further analysis of Phase III COMFORT™ data show Piclidenoson's superior safety profile and higher patient compliance compared to Otezla® Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CFBI), a

CANF

Clover Health Granted U.S. Patent #11508465: Systems and methods for determining event probability

Related Posts

Bed Bath & Beyond Reports In Form4 Filing CFO Gustavo Arnal Sells 55,013 Shares At Average Price Of $25.52/Share

CrowdStrike Achieves IL5 Authorization To Secure U.S. Department Of Defense

374Water Inc Files For Mixed Shelf Of Up To $200M

Can-Fite To Submit FDA & EMA Registration Plans For Piclidenoson In The Oral Treatment Of Moderate To Severe Psoriasis